Patent: 10,611,809
✉ Email this page to a colleague
Summary for Patent: 10,611,809
| Title: | Single-domain antibody fusion proteins with the acid tail of alpha-synuclein |
| Abstract: | A single-domain antibody (sdAb) is produced by causing a bacteria to express the sdAb into cytoplasm of the bacteria, wherein the sdAb is expressed as a fusion protein with the acid tail of α-synuclein. In embodiments, the protein is free of a periplasmic location tag. Such antibodies have the unexpected ability to refold after thermal denaturation. |
| Inventor(s): | Daniel Zabetakis, George P. Anderson, Ellen R. Goldman, Kendrick Turner, P. Audrey Brozozog Lee |
| Assignee: | US Department of Navy |
| Application Number: | US16/365,900 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,611,809
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | ABRYSVO | respiratory syncytial virus vaccine | Injection | 125769 | May 31, 2023 | ⤷ Get Started Free | 2039-03-27 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,611,809
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 2019211069 | ⤷ Get Started Free |
| United States of America | 2019211068 | ⤷ Get Started Free |
| United States of America | 2015203548 | ⤷ Get Started Free |
| United States of America | 10577401 | ⤷ Get Started Free |
| United States of America | 10294283 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
